Targeted agents and immunotherapies: optimizing outcomes in melanoma
University of Chicago · Harvard University · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,280
total citations
- FWCI
- 53.93
- Percentile
- 100%
- References
- 173
Citations per year
Authors
4- JJJason J. LukeCorresponding
University of Chicago
- KTKeith T. Flaherty
Harvard University, Massachusetts General Hospital
- ARAntoni Ribas
University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center
- GVGeorgina V. Long
University of Sydney, Royal North Shore Hospital, Mater Misericordiae Hospital, Melanoma Institute Australia
Topics & keywords
Topics
Keywords
- Medicine
- Melanoma
- Immunotherapy
- Trametinib
- Oncology
- Targeted therapy
- Dabrafenib
- Clinical trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.